BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ceccarelli M, Bani D, Cinci L, Nistri S, Uliva C, Ragazzo E, Vannacci A, Manoni M, Gori AM, Abbate R, Gensini GF, Masini E. Anti-inflammatory effects of low molecular weight heparin derivative in a rat model of carrageenan-induced pleurisy. J Cell Mol Med 2009;13:2704-12. [PMID: 20141620 DOI: 10.1111/j.1582-4934.2009.00658.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Culbert MH, Hamidi M, Zeeshan M, Hanna K, Romero A, Joseph B, O'keeffe T. Retrospective Analysis of Low-Molecular-Weight Heparin and Unfractionated Heparin in Pediatric Trauma Patients: A Comparative Analysis. Journal of Surgical Research 2020;249:121-9. [DOI: 10.1016/j.jss.2019.11.019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Paschoa AF. Heparin: 100 years of pleiotropic effects. J Thromb Thrombolysis 2016;41:636-43. [DOI: 10.1007/s11239-015-1261-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
3 Arachchillage DRJ, Mackie IJ, Efthymiou M, Chitolie A, Hunt BJ, Isenberg DA, Khamashta M, Machin SJ, Cohen H. Rivaroxaban limits complement activation compared with warfarin in antiphospholipid syndrome patients with venous thromboembolism. J Thromb Haemost 2016;14:2177-86. [DOI: 10.1111/jth.13475] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 5.2] [Reference Citation Analysis]
4 Papageorgiou N, Zacharia E, Briasoulis A, Charakida M, Tousoulis D. Celecoxib for the treatment of atherosclerosis. Expert Opinion on Investigational Drugs 2016;25:619-33. [DOI: 10.1517/13543784.2016.1161756] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
5 Makarchian HR, Kasraianfard A, Ghaderzadeh P, Javadi SM, Ghorbanpoor M. The effectiveness of heparin, platelet-rich plasma (PRP), and silver nanoparticles on prevention of postoperative peritoneal adhesion formation in rats. Acta Cir Bras. 2017;32:22-27. [PMID: 28225914 DOI: 10.1590/s0102-865020170103] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
6 Lansley SM, Cheah HM, Lee YC. Role of MCP-1 in pleural effusion development in a carrageenan-induced murine model of pleurisy. Respirology 2017;22:758-63. [PMID: 27878909 DOI: 10.1111/resp.12951] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
7 Zhao G, Seng J, Beagle J, Syrkina O, Hales CA. Heparin reduces overcirculation-induced pulmonary artery remodeling through p38 MAPK in piglet. Ann Thorac Surg 2015;99:1677-84. [PMID: 25818573 DOI: 10.1016/j.athoracsur.2014.12.061] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
8 Poli M, Girelli D, Campostrini N, Maccarinelli F, Finazzi D, Luscieti S, Nai A, Arosio P. Heparin: a potent inhibitor of hepcidin expression in vitro and in vivo. Blood. 2011;117:997-1004. [PMID: 21076043 DOI: 10.1182/blood-2010-06-289082] [Cited by in Crossref: 94] [Cited by in F6Publishing: 95] [Article Influence: 7.8] [Reference Citation Analysis]
9 Li P, Sheng J, Liu Y, Li J, Liu J, Wang F. Heparosan-derived heparan sulfate/heparin-like compounds: one kind of potential therapeutic agents. Med Res Rev 2013;33:665-92. [PMID: 22495734 DOI: 10.1002/med.21263] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 3.4] [Reference Citation Analysis]
10 Janse van Rensburg A, Davies NH, Oosthuysen A, Chokoza C, Zilla P, Bezuidenhout D. Improved vascularization of porous scaffolds through growth factor delivery from heparinized polyethylene glycol hydrogels. Acta Biomater 2017;49:89-100. [PMID: 27865963 DOI: 10.1016/j.actbio.2016.11.036] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
11 Khurrum M, Asmar S, Henry M, Ditillo M, Chehab M, Tang A, Bible L, Gries L, Joseph B. The survival benefit of low molecular weight heparin over unfractionated heparin in pediatric trauma patients. J Pediatr Surg 2021;56:494-9. [PMID: 32883505 DOI: 10.1016/j.jpedsurg.2020.07.021] [Reference Citation Analysis]